From: CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia
Lymphocyte sub-type | Average % CD39+ cells (range) | Mean expression of CD39 per cell |
---|---|---|
Total normal lymphocytes | 20* (14–23) | 2463** (1800–3000) |
T-lymphocytes (CD3+) | 8.2* (1.2–15) | 1717* (900–2700) |
CD4+ | 9.1* (1.8–16) | 1942* (1300–2700) |
CD8+ | 7.9* (0.7–22) | 949*,†(400–1500) |
B-lymphocytes (CD19+) | 95 (87–99) | 3640 (2100–5000) |
Malignant B-lymphocytes | 93 (61–100) | 3480 (600–9000) |